Leading US psychiatric experts join Oryzon’s Clinical Advisory Board (CAB) to advance Phase III development of vafidemstat in Borderline Personality Disorder (BPD) CAB and Oryzon establish primary and ...
Many people have heard of borderline personality disorder (BPD) and much of what they have heard is negative. People with this disorder face damaging stigma, partly due to being portrayed in unfair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback